BMD
WST icon

Better Money Decisions’s West Pharmaceutical WST Stock Holding History

Better Money Decisions’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30
Closed -$9K – 453
2022
Q2 		$9K Buy
+30
New +$9.76K 0.01% 339
2021
Q4 		– Sell
-30
Closed -$13K – 586
2021
Q3 		$13K Hold
30
– – 0.01% 355
2021
Q2 		$11K Hold
30
– – 0.01% 374
2021
Q1 		$8K Buy
+30
New +$8.59K 0.01% 390

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Better Money Decisions's WST Position: Q3 2022 in Review

Better Money Decisions sold out of West Pharmaceutical (WST) in Q3 2022, closing a stake of 30 shares — an estimated $9K sold.

Better Money Decisions first reported a position in WST in Q1 2021 and held it in 4 quarters. The position peaked at $13K in Q3 2021. 637 funds tracked by Wall St. Rank hold WST as of Q3 2022.

  • Better Money Decisions reported no remaining West Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • Better Money Decisions sold 30 West Pharmaceutical shares in Q3 2022, an estimated $9K.
  • Better Money Decisions first reported a position in West Pharmaceutical in Q1 2021 and held it in 4 quarters.
  • Better Money Decisions's West Pharmaceutical position peaked at $13K in Q3 2021.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2022.

Based on Better Money Decisions's 13F filing for Q3 2022, filed 28 Oct 2022.